image
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Arthroscopic Techniques
Case Report
Case Series
Current Issue
Editorial
Elbow, Review Article
Foot and Ankle, Review Article
Guest Editorial
Hip, Review Article
Invited Review
Knee, Review Article
Letter to the Editor
Media and news
Narrative Review
Original Article
Regenerative Orthopaedics, Review Article
Review Article
Shoulder, Review Article
Spine, Review Article
Systematic Review and Meta-analysis
test2-issue
Video of Arthroscopic Surgical Procedures
Wrist, Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Arthroscopic Techniques
Case Report
Case Series
Current Issue
Editorial
Elbow, Review Article
Foot and Ankle, Review Article
Guest Editorial
Hip, Review Article
Invited Review
Knee, Review Article
Letter to the Editor
Media and news
Narrative Review
Original Article
Regenerative Orthopaedics, Review Article
Review Article
Shoulder, Review Article
Spine, Review Article
Systematic Review and Meta-analysis
test2-issue
Video of Arthroscopic Surgical Procedures
Wrist, Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Arthroscopic Techniques
Case Report
Case Series
Current Issue
Editorial
Elbow, Review Article
Foot and Ankle, Review Article
Guest Editorial
Hip, Review Article
Invited Review
Knee, Review Article
Letter to the Editor
Media and news
Narrative Review
Original Article
Regenerative Orthopaedics, Review Article
Review Article
Shoulder, Review Article
Spine, Review Article
Systematic Review and Meta-analysis
test2-issue
Video of Arthroscopic Surgical Procedures
Wrist, Review Article
View/Download PDF

Translate this page into:

Narrative Review
ARTICLE IN PRESS
doi:
10.25259/JASSM_7_2026

Management of chondromalacia patellae in elite athletes: Balancing high-performance demands with joint preservation

Department of Orthopaedics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

*Corresponding author: Sujit Kumar Tripathy, Department of Orthopaedics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India. sujitortho@yahoo.co.in

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Tripathy SK, Khan S, Bhagat A, Jain M. Management of chondromalacia patellae in elite athletes: Balancing high-performance demands with joint preservation. J Arthrosc Surg Sports Med. doi: 10.25259/JASSM_7_2026

Abstract

Background and Aims:

Chondromalacia patellae presents a unique and significant challenge for elite athletes. It is not just a source of discomfort but a condition that can disrupt demanding training schedules, competitive performance, and the long-term durability of a sporting career.

Materials and Methods:

This narrative review synthesizes current evidence on the diagnosis and management of chondromalacia patellae in elite athletes, focusing on clinical evaluation, imaging, and treatment strategies.

Results:

The condition arises from a combination of anatomical, biomechanical, and training-related factors, including subtle malalignment, muscle imbalances, and the repetitive, high-load demands inherent to elite sport. Diagnosis is a careful blend of a thorough clinical assessment and advanced imaging, particularly magnetic resonance imaging, to visualize cartilage health and identify contributing structural issues. Treatment involves a multidisciplinary approach that strategically modulates biological healing capacity, biomechanical forces on the knee, and the athlete’s performance demands. A structured, phased rehabilitation program forms the cornerstone, progressing from pain control to strength restoration and ultimately to sport-specific retraining. When conservative measures are insufficient, a spectrum of advanced surgical options exists to restore cartilage or correct underlying malalignment.

Conclusion:

A personalized, multimodal approach is essential. While rehabilitation remains the cornerstone, biologic therapies and precision surgical interventions may aid selected patients. The primary goal is safe return to sport while preserving long-term joint health.

Keywords

Chondromalacia patellae
Knee
Orthobiologics
Osteotomy
Patella alta

INTRODUCTION

Chondromalacia patellae (CMP), sometimes known as Runner’s knee or patellofemoral pain syndrome (PFPS), is a major clinical problem in elite athletes, often manifesting as anterior knee pain. Around 25–30% of all sports injuries are CMP, usually involving athletes involved in jumping and pivoting sports such as basketball, volleyball, athletics, football, and rock climbing.[1] The softening and degeneration of the patellar articular cartilage characterize this condition. This disorder can be managed in the general population using standard rehabilitation techniques. When it comes to high-performance athletes, the situation is considerably more complex. Their competitive schedules, focused training plans, and high biomechanical loads are what make their careers unique. In addition to being a symptom, anterior knee pain may jeopardize an athlete’s ability to compete at their best, stay in sports for a long time, and succeed professionally.

A paradigm beyond traditional algorithms is required to treat chondromalacia in this cohort. In addition to high functional demands and unique physiological adaptations, elite athletes also face unavoidable time constraints on their return to sport (RTS). The pathophysiology is often the result of complex, sport-specific factors, such as repetitive microtrauma, dynamic malalignment arising from severe muscular imbalances, subtle patellar instability, and the cumulative effect of training volumes above normal physiological thresholds. In this situation, a comprehensive and precise approach to diagnosis and treatment is required.

The approaches to manage this condition must carefully balance preserving the strength, power, and neuromuscular accuracy required for elite sports with reducing discomfort and halting cartilage deterioration. To restore articular homeostasis without compromising athletic ability, a multidisciplinary approach is needed, combining comprehensive biomechanical analysis, personalized regenerative medicine techniques, intelligent load management, and, when required, minimally invasive surgical procedures.

In this narrative review, we consolidate the best available evidence and expert consensus. We will critically examine the roles of cutting-edge biological treatments, intelligent rehabilitation sequencing, and precision surgery, all guided by the principle of performance preservation. The ultimate goal is to provide the sports medicine orthopedic surgeon with the evidence and strategic insights necessary to guide elite athletes not only back to play but also back to dominance, while safeguarding the long-term health of the patellofemoral joint (PFJ).

EPIDEMIOLOGY

Young, active populations are more likely to have chondromalacia patella. Although many cases are asymptomatic, its frequency is significant but ambiguous, with 15–30% of young athletes exhibiting clinical signs.[1,2]

High levels of exercise and growth-related biomechanical changes are associated with an incidence peak that occurs during adolescence and early adulthood (ages 15–35).[3] Due to anatomical differences (wider pelvis and higher Q-angle), hormonal effects on cartilage, and differences in muscle strength and dynamic alignment, it is more common in females (about 2:1 female-to-male ratio), demonstrating a pronounced gender imbalance.[3]

PATHOGENESIS

The pathogenesis of chondromalacia patella involves a multifactorial interplay between mechanical overload, biochemical degradation, and impaired cartilage homeostasis. CMP develops secondary to patella dislocation or subluxation. This subluxation or dislocation may be subtle or obvious. This can be due to a major traumatic episode or repeated microtrauma resulting from abnormal anatomy or abnormal alignment of the lower limb, as described below [Figure 1]. Ultimately, this leads to softening, fibrillation, and breakdown of the patellar articular cartilage.

Pathogenesis of chondromalacia patellae. VMO: Vastus medialis obliquus, IT: Iliotibial
Figure 1:
Pathogenesis of chondromalacia patellae. VMO: Vastus medialis obliquus, IT: Iliotibial

Femur

This is the most critical femoral structure related to chondromalacia. The shape and depth of the trochlea play an essential role in stabilizing the patella. It acts as the “railroad track” for the patella. During knee flexion and extension, the patella should glide smoothly within this groove. A dysplastic trochlea (shallow, flat, or even convex trochlear groove) is a significant risk factor for dislocation and fails to properly contain the patella, leading to instability, maltracking, and excessive lateral forces on the patellar cartilage in 85–90% cases.[4] This repeated maltracking leads to cartilage erosion from the patellar facet.

The lateral femoral condyle has a more prominent anterior projection and is bigger than the medial condyle. This acts as a bumper, helping prevent lateral patellar dislocation. In a normal knee, the lateral condyle provides a lateral restraint. If the trochlea is dysplastic, this restraining function is lost. The patella can slip laterally, causing abnormal pressure on its articular surface.

Patella

Patellar shape, size, and location play an essential factor in the pathogenesis of chondromalacia.

Patellar shape was first classified by Wiberg in 1941.[5] A slightly more convex medial patellar facet (Wiberg type III and IV) is more prone to dislocation. A voluminous patella exerts higher forces at the patellofemoral (PF) joint during isometric and isotonic quadriceps contraction. Increased joint reaction forces lead to repeated microtrauma on the hyaline cartilage in the PF joint. High joint reaction forces also squeeze the synovial fluid out of the articular surface, which leads to cartilage degeneration and increased friction at the joint surface.[6]

Furthermore, a high-riding patella (patella alta) engages the trochlea in later stages of flexion, which makes it prone to dislocation. This is determined by the Insall-Salvati or the Caton-Deschamps index.

Medial patellofemoral ligament (MPFL)

The MPFL is frequently torn or attenuated in patellar instability.[7] MPFL is the primary soft tissue restraint for lateral patellar instability. The 5.5 cm long, hourglass-shaped MPFL ligament serves as a checkrein to stop the patella from lateralizing during the knee range of motion, especially in early flexion.[8]

Other soft tissue changes

Other soft tissue changes that may contribute to patellar instability are a tight lateral retinaculum and a lax medial retinaculum.

Quadriceps femoris

This muscle plays a vital role in stabilizing the patella. The combined pull of the four quadriceps muscles creates a net force vector that runs relatively straight down the thigh, through the patella, and to the tibial tuberosity. A dynamic relation between the pull of vastus lateralis and vastus medialis obliquus determines the patella tracking. An excessive pull of the vastus lateralis or weakness in the vastus medialis creates a net lateral pull over the patella, leading to lateral subluxation. Recent studies have shown that an increase in the thickness of the patellar and quadriceps tendons exerts backward forces on the patella, leading to premature cartilage degeneration.[9]

Q angle is another important parameter, formed by the intersection of lines from the anterior superior iliac spine to the patella midpoint and from the patella midpoint to the tibial tubercle. Normal values are generally 12–15° in males and 13–18° in females. Higher angles are associated with an increased risk of PFPS and lateral patellar tracking issues, and this explains the female predominance.

Alignment of the lower limb

Chondromalacia patella (CP) is influenced by lower limb alignment, which is a biomechanical component. The malalignment of the lower limb alters the vector of the quadriceps and the loading of the PFJ, causing excessive pressure on the lateral PFJ and cartilage deterioration.

The alignment factors include:

Static malalignment

A larger Q angle (often >20° in women, >15° in men) increases the lateral pull on the patella, a classic risk factor for lateral facet overload and (CP). On the one hand, the valgus malalignment increases the Q-angle, which in turn increases the stress on the lateral PFJ. On the other hand, varus malalignment at the knees leads to medial PFJ overload, which can cause cartilage degeneration.

Dynamic malalignment (more significant than static)

Weak hip abductors/external rotators (gluteus medius) lead to excessive femoral internal rotation during weight-bearing, causing a “functional” valgus and lateral patellar tracking. Excessive pronation of the foot causes internal tibial rotation, twisting the patellar tendon attachment and increasing lateral patellar tilt.

Rotational malalignment

Excessive femoral anteversion and tibial extorsion create a “miserable malalignment syndrome,” causing rotational mismatch and severe patellar maltracking.

THE BIOMECHANICAL RELATIONSHIP: THE PFJ

Chondromalacia is essentially a disorder of the PFJ – the articulation between the patella and the femoral trochlea. Proper tracking depends on a complex balance of forces (from the quadriceps, patellar tendon, and ligaments) and the bony anatomy of both the femur and the patella.

During full extension, the patella sits above the groove. In early flexion (20–30°), the patella engages the groove. This is the most critical point for stability. In deep flexion (more than 90°), the patella is fully seated in the intercondylar notch and very stable.

If femoral anatomy is abnormal (e.g., shallow trochlea), contact pressures become concentrated on a smaller area of the patellar cartilage, leading to overload, softening, and breakdown of cartilage.

CLINICAL DIAGNOSIS: THE CORNERSTONE

Chondromalacia patella usually presents as insidious-onset, poorly localized anterior, retro-patellar, or peripatellar pain.

The pain is exacerbated by activities loading the PFJ in flexion: ascending/descending stairs, squatting, prolonged sitting (“theatre sign”), and rising from a seated position.[10]

Sensations of grating, crepitus, or catching may be present but are non-specific. True subluxation of the patella is uncommon, but patients more frequently report a sense of “giving way” due to pain inhibition.

Examination of the knee joint aims to reproduce symptoms and identify contributing biomechanical factors. Assessment of quadriceps bulk, lower limb alignment (femoral anteversion, knee valgus, foot pronation) is necessary. Tenderness on palpation of the patellar facets (especially medial) with the knee extended and relaxed. Synovial or fat pad tenderness may coexist.

A positive Clarke’s sign and a J-sign point toward a patellar instability. It is crucial to rule out other pathologies, such as patellar tendon tendinopathy, pes anserine bursitis, and Hoffa fat pad syndrome. The anatomical location of these structures can help differentiate between the pathologies. Assessment of hip abductor strength is necessary, as weak hip abductors are frequently associated with weak external rotators.[10] A weak external rotator or hip abductor makes the femur more prone to internal rotation. This makes the patella sublux laterally. At the end, one must not forget to look for the signs of hyperlaxity.

IMAGING: CONFIRMATORY AND STAGING ROLE

Imaging confirms the diagnosis, grades the severity, and excludes other pathologies. It should always be interpreted in the context of clinical findings. The algorithm for diagnosis is summarized in Figure 2.

Algorithm for diagnosis of chondromalacia patella. PFPS: Patellofemoral pain syndrome, AP: Anteroposterior.
Figure 2:
Algorithm for diagnosis of chondromalacia patella. PFPS: Patellofemoral pain syndrome, AP: Anteroposterior.

Radiography (first-line)

Weight-bearing anteroposterior and lateral views

X-rays are used to detect other conditions that may cause anterior knee pain and to evaluate the PFJ. This helps assess overall alignment, trochlear morphology, patellar alta (InsallSalvati ratio >1.2, Caton-Deschamps ratio >1.3), and signs of osteoarthritis. Furthermore, it helps to rule out fractures, osteoarthritis, osteochondral defects, loose bodies, tumors, or significant joint space narrowing.

Axial (merchant/sunrise) view at 30–45° of flexion

This view is essential for evaluating PF congruence, lateral patellar tilt, and subluxation. It can show joint space narrowing and osteophyte formation, but does not visualize cartilage directly. An increased sulcus angle with a positive congruence angle is a risk factor for patellar instability. Furthermore, the lateral patellar displacement ratio is <0.05–0.10. Ratios >0.20 are strongly associated with patellar instability and a history of dislocation.

Magnetic resonance imaging (MRI)

MRI has emerged as the non-invasive gold standard for evaluating PF cartilage, surpassing the capabilities of conventional radiography and even diagnostic arthroscopy for pre-operative planning due to its ability to assess the entire osteochondral unit.

MRI protocol for cartilage lesions

A dedicated knee MRI protocol for assessing PF cartilage must include high-resolution sequences with a high contrast-to-noise ratio between cartilage, synovial fluid, and subchondral bone. Key sequences include:

Fat-suppressed proton density or T2-weighted fast spin-echo sequences

These are the primary sequences for morphological assessment. Fat suppression is critical for detecting concomitant bone marrow edema, a significant source of pain. They provide excellent detail of cartilage surface integrity and underlying bone.

Three-dimensional (3D) gradient-echo sequences

These include spoiled gradient recalled or dual echo in steady state sequences. These allow for thin, contiguous slices (<1.5 mm) and are excellent for volumetric assessment and detecting subtle surface irregularities.[11]

Intermediate-weighted fat-suppressed sequences

These sequences offer an optimal balance between T1 and T2 weighting, providing high contrast between bright synovial fluid and intermediate-signal cartilage, making fissures and defects more conspicuous.

Advanced quantitative sequences

T2 mapping

This sequence helps quantify collagen matrix integrity and hydration. Early chondromalacia often shows elevated T2 values due to increased water content and collagen disorganization before morphological changes are visible.

T1rho mapping

This sequence is highly sensitive to loss of proteoglycan content in the cartilage extracellular matrix, another early biochemical marker of degeneration.

Delayed gadolinium-enhanced MRI of cartilage

This sequence assesses glycosaminoglycan (GAG) concentration by measuring T1 relaxation time after intravenous gadolinium administration. Lower GAG correlates with early degeneration.

MRI findings include cartilage changes, which are graded according to outerbridge or International Cartilage Repair Society (ICRS) classification systems [Tables 1 and 2].[12] Additional changes include bone marrow edema in the patella or trochlea (“kissing lesions”), synovitis, effusion, trochlear dysplasia, and lateral patellar tilt.

Table 1: Outerbridge (modified) grading system for chondromalacia patella lesions.
Grades Cartilage status
Grade I Focal signal change/intralesional softening (swelling)
Grade II Partialthickness defect/fibrillation <50% depth
Grade III Fissuring/fibrillation >50% depth, not to subchondralbone
Grade IV Fullthickness cartilage loss with exposed subchondral bone.
Table 2: ICRS cartilage grading scale.
Grading Cartilage status
Grade 0 Healthy, normal cartilage
Grade 1 Superficial lesions, including soft indentation, superficial fissures, and cracks
Grade 2 Partialthickness defect, with lesions extending downto<50% of the cartilage depth
Grade 3 Deep cartilage defects, extending down more than 50% of the depth, extending down to the calcified layer, or blisters
Grade 4 Fullthickness cartilage defect with exposure of the subchondral bone.

ICRS: International Cartilage Repair Society

Computed tomography (CT)

CT plays a secondary, specialized role in the management of CMP primarily due to its poor soft-tissue contrast resolution. Unlike MRI, CT cannot directly visualize early cartilage softening, fibrillation, or edema. Its ionizing radiation exposure further limits routine use. However, CT has specific, valuable applications in certain clinical contexts where bone morphology, alignment, and advanced degenerative changes require detailed assessment.[13]

Assessment of PF malalignment and trochlear dysplasia, like patellar tilt and translation, trochlear morphology, trochlear depth, sulcus angle, and lateral trochlear inclination, more accurately. A TT-TG distance >20 mm is a strong indication for a distal realignment procedure.[4]

CT also reveals secondary bony abnormalities in late-stage CMP (Outerbridge Grade IV) that might not be clearly visible on MRI. Osteophytes and variations in subchondral bone density are shown on high-resolution CT. CT can also detect intra-articular loose pieces. When surgical management is planned, 3D CT provides essential insights into osseous anatomy for precise surgical planning.

CT arthrography (CTA)

While replaced mainly by MRI, CTA (injection of iodinated contrast into the joint before CT) has a niche role. The contrast outlines the cartilage surface, allowing indirect assessment of its contour. It is usually performed in patients with contraindications to MRI (e.g., certain pacemakers, severe claustrophobia) or when metallic artifact from prior hardware obscures MRI evaluation. CTA can provide a reasonable assessment of full-thickness cartilage defects.[14] However, it is invasive, involves radiation and iodinated contrast, and is inferior to MRI for assessing bone marrow edema, partial-thickness lesions, and early chondromalacia.

Diagnostic ultrasound

The use of USG in the assessment of suspected CMP is minimal. Its primary advantage is that it is a dynamic, real-time, and easily accessible imaging technology that can assess cartilage during joint movement and provocation movements. Significant restrictions, however, limit its application to a supplementary role in conjunction with MRI, the gold standard for diagnosis.[15]

TREATMENT

Foundational principles: The “Load Triangle”

Management revolves around modulating three axes of load:

  1. Biological capacity: Enhancing tissue health and repair

  2. Biomechanical load: Optimizing force distribution across the PFJ

  3. Performance demand: Strategically managing training volume and intensity [Table 3].

Table 3: Proposed management algorithm of chondromalacia patella for the elite athlete.
Grade/severity Primary treatment path Secondary/salvagepath
Grade I–II (Stable) Nonoperative: Intensive rehab+load management Consider PRP injections for symptomatic relief
Grade IIIIV (<2–3 cm2) Osteotomies±biologic/regenerative: BMAC injection+specialized rehab If fails: Combine with OATs or MACI
Diffuse/bipolar (endstage) Arthroplasty: Patellofemoral arthroplasty Joint preservation/RTS in lowimpact sports.

PRP: Platelet-rich plasma, OATs: Osteochondral autograft transplantation, MACI: Matrix-induced autologous chondrocyte implantation, BMAC: Bone marrow aspirate concentrate, RTS: Return to sport

STAGE-DIRECTED NON-OPERATIVE MANAGEMENT

Non-operative treatment should be tried first before opting for surgical treatment. At least 1 year of conservative treatment must be tried in patients with chondromalacia patella. However, in athletes, operative treatment can be sought earlier. The optimal timing for surgery for a cartilage defect remains unknown.

The conservative trial is implemented in 3 phases:

Phase I: Acute modulation and symptom control (weeks 0–2)

Load management

In this phase, the athletes are offered “relative rest.” This involves reducing impact and high-flexion activities (squats, stairs) by 50–70%. The athletes utilize cross-training (pool running, anti-gravity treadmills) to maintain cardiopulmonary fitness without exacerbating pain (Visual Analog Scale [VAS] <3/10).

Pain and inflammation management

This is achieved by a short course of non-steroidal anti-inflammatory drugs and cryotherapy. Further analgesics like opioids may be administered based on the requirement. Control of pain and inflammation is essential for early rehab.

Early rehabilitation

Initially, the isometric exercises are encouraged. Isometric quadriceps exercises (straight leg raises, quad sets) at multiple angles, with vastus medialis obliquus (VMO) strengthening, must be performed along with hip and ankle strengthening.

Phase II: Targeted rehabilitation and load progression (weeks 2–12)

Strength and neuromuscular control

Gradual progression to eccentric exercises (e.g., decline single-leg squats, Nordic hamstring curls for the posterior chain) is carried out after 2 weeks. This increases the tendon and cartilage tolerance.[16] The proximal muscles, like gluteus medius/maximus, are strengthened during this period to control femoral internal rotation/adduction and reduce dynamic valgus. Further VMO strengthening is done to reduce the stress on the lateral patellar facet.

Load reintegration

A stepwise, symptom-guided progression from low-impact bilateral to high-impact unilateral activities is then followed. During this phase, the trainers must ensure that the pain activity is controlled (Target VAS <5) and subsides within 24 h of activity cessation. Although this pain control model has been applied to Achilles tendinopathy, it also holds good for knee injuries.[17]

Adjunctive treatment

This includes bracing and taping. Medial glide or McConnell taping for the patella can be used for symptomatic relief during sport-specific training. PF braces with a lateral buttress may be considered for athletes with maltracking. One may consider foot orthoses, such as arch-support insoles and deep heel cups, if significant biomechanical foot issues, such as excessive pronation, are noted.

Phase III: Sport-specific retraining and RTS

Although the exact timing of RTS in chondromalacia patella is still a matter of debate, pain-free isometric contraction, single-leg squat to 60°, and hip strength symmetry >85% can be used as surrogate markers.[1] This varies according to the sports the athletes are involved in. A graduated introduction to plyometrics, focusing on the quality of landing mechanics, is essential. A structured RTS continuum over 4–8 weeks is critical to prevent recurrence.

RECENT ADVANCES IN BIOLOGICAL AND ADJUNCTIVE THERAPIES

Injectable orthobiologics

Platelet-rich plasma (PRP)

PRP shows promise for symptomatic improvement and potential cartilage modulation in early-stage chondromalacia (Outerbridge I-II).[18] However, evidence for altering structural progression in athletes remains limited. If used at all, a leukocyte-deficient PRP must be administered. An initial inflammatory response may be expected after the injection, which subsides with time. This inflammatory phase must be managed with rest and ice pack applications.

Bone marrow aspirate concentrate

It contains mesenchymal stem cells (MSCs) and growth factors. Emerging as a potential option for focal, contained Grade III–IV lesions in athletes wishing to delay or avoid surgery, though high-level evidence is still evolving. Furthermore, the high cost of treatment limits its use in clinical practice. An inflammatory reaction may occur after injection, similar to that seen with PRP.

Viscosupplementation

Although strictly not an orthobiologic, these agents can be used for the treatment of chondromalacia. These agents also reduce inflammation and enhance patellar gliding. Only a handful of studies have been conducted on patients with chondromalacia, but the results are pretty encouraging.[19,20]

MSCs

Injecting pluripotent MSCs derived from adipose tissues has proven to be beneficial in the management of CMP. The adipocytes are retrieved from the patient through liposuction and treated to generate the MSCs.[21] The MSC suspension is then injected into the knee. The MSCs get activated into chondrocytes by transforming growth factor-beta, which replaces the cells.[22] The MSCs also help control the inflammatory milieu and contribute to healing.

SURGICAL MANAGEMENT: INDICATIONS AND PRECISION TECHNIQUES

Surgery is indicated by symptomatic, high-grade (III–IV) localized lesions, concomitant instability/malalignment, or failure of 6 months of intensive, sport-specific rehabilitation. The following are numerous surgical options.

Cartilage restoration/repair

Microfracture

This technique is also used for small lesions. The degenerated cartilage is debrided, and a punch is used to remove the degenerated part. An osteochondral plug is extracted from the lesser articulating portion of the superolateral trochlear groove with the help of a punch or reamers. This plug is then placed on the debrided cartilage.[23-25] This is usually performed by medial arthrotomy. For larger lesions, multiple osteochondral plugs can be harvested and implanted. A recent review by Donoso et al. found that osteochondral autograft transplantation (OAT) is a highly efficient way of treating high-grade patellar chondral lesions.[26]

OATs/mosaicoplasty

This technique is also used for small lesions. The degenerated cartilage is debrided, and a punch is used to remove the degenerated part. An osteochondral plug is extracted from the lesser articulating portion of the superolateral trochlear groove with the help of a punch or reamers. This plug is then placed on the debrided cartilage.[25] This is usually performed by medial arthrotomy. For larger lesions, multiple osteochondral plugs can be harvested and implanted. A recent review by Donoso et al. found that OATs are a highly efficient way of treating high-grade patellar chondral lesions.[26]

PF allografts

Recently, authors have tried using PF allografts and have demonstrated success. The osteochondral allograft completely integrates with the host bone.[27] These can be used in skeletally immature patients at risk of physeal injury during harvesting of the femoral autograft. However, there are no randomized controlled trials (RCTs) involving the use of an allograft.

Matrix-induced autologous chondrocyte implantation (MACI)

Chondrocyte implantation (CI) restores the hyaline cartilage as opposed to fibrocartilage obtained after microfracture. It is a two-stage procedure: The first stage involves harvesting chondrocytes, either arthroscopically or through an open procedure, followed by in vitro culture and cell expansion. In the second stage, these cells are then replanted into the cartilage defect [Figure 3]. Autologous chondrocyte implantation (ACI) may be considered in larger full-thickness chondral defects (>2 cm2) on the patella or trochlea. However, this procedure requires prolonged RTS (9–12+ months) but offers hyaline-like repair. This technique certainly has favorable outcomes as compared to the previously mentioned techniques.[28]

Autologous chondrocyte implantation for chondromalacia patella. (A and B) The lesion present on the lateral facet of petalla was debrided. (C and D) Then, cultured chondrocytes mixed with thrombin and fibrin were put to the defect site.
Figure 3:
Autologous chondrocyte implantation for chondromalacia patella. (A and B) The lesion present on the lateral facet of petalla was debrided. (C and D) Then, cultured chondrocytes mixed with thrombin and fibrin were put to the defect site.

Realignment procedures (for malalignment/instability)

Realignment procedures correct the anatomical anomaly leading to chondromalacia patella. These include various osteotomies around the knee joint to restore the normal anatomy and prevent patella subluxation. These include:

MPFL reconstruction

Since the MPFL is the primary restraint to lateral patella subluxation from 0° to 30° of flexion, this procedure is the gold standard for recurrent patella instability. It involves anatomic and isometric reconstruction of the MPFL. A semitendinosus or a gracilis autograft replaces the incompetent MPFL.

The graft is secured at Schottle’s point on the femoral side, which lies 1 mm anterior to the tangent to the posterior femoral cortex, 2.5 mm distal to the perpendicular line traced through the initial part of the medial femoral condyle, and proximal to the vertical line traced through the most posterior part of Blumensaat’s line. Care must be taken not to damage the physis in case of skeletally immature athletes. In such cases, the semitendinosus autograft can be suspended around the adductor longus tendon instead of drilling the femoral bone. The patellar attachment lies at 7.4 ± 3.5 mm anterior to the posterior patellar cortical line, 5.4 ± 2.6 mm distal to the perpendicular line intersecting the proximal margin of the patellar articular surface.[29]

The complications of this procedure range from 0% to 32.3%.[30] The most common complication is the stiffness of the knee (20%), followed by failure of the graft (10.7%) and patella fractures (8.3%).[30] The prevalence of persistent anterior knee discomfort has been reported to range from 0% to 32.3% in patients. Hence, early physiotherapy is indicated after surgery.

Tibial tubercle osteotomy (TTO)

This surgery is performed in cases of high-riding patella. The tibial tubercle is osteotomized with an oscillating saw. The osteotomized tubercle should be at least 2 cm in breadth and 8–10 cm in length. The osteotomized tubercle is then released from its soft-tissue attachments. It is then anteriorized, distalized, or medialized depending on the requirement and fixed using plates or screws.[31-33] TTO has the following variants based on the direction of movement of the tibial tubercle. This surgery is performed in cases of high-riding patella. The tibial tubercle is osteotomized with an oscillating saw. The osteotomized tubercle should be at least 2 cm in breadth and 8–10 cm in length. The osteotomized tubercle is then released from its soft-tissue attachments. It is then anteriorized, distalized, or medialized depending on the requirement and fixed using plates or screws.[31] TTO has 3 variants based on the direction of tibial tubercle movement.

Anteriorization (Maquet)

Anteriorization of the tibial tubercle is achieved by placing a bone graft below the tibial tubercle. This reduces the patella-femoral contact forces. Maquet revealed that a 2 cm anteriorization reduced PF contact forces by 50%.[32] It is helpful in the management of combined chondrosis and instability.[32] However, this technique carries a complication rate of 10–30%, mostly leading to skin necrosis and prominence of hardware, compartment syndrome, and non-union.[33] Hence, this technique is not popular nowadays.

Medialization (Elmslie-Trillat)

The primary indication for this surgical technique is patellar instability or lateral maltracking. Medialization of the tibial tubercle reduces the lateral maltracking. If done correctly, it reduces the recurrence rates to <7%.[34]

Anteromedialization (Fulkerson/Antero-Mediali-Zation [AMZ])

The procedure of choice for athletes with instability and significant lateral facet overload/chondrosis. This is a combination of the methods mentioned above. Initially described by Fullkerson et al. in 1983, this technique is the main workhorse in the management of PFPS today. The indications include PF pain not responding to non-operative interventions and patellar maltracking (including instability) or excessive tilt.[35] Lateral and distal chondral wear is the usual pattern of wear associated with lateral maltracking of the patella. In addition to allowing the patella to make contact with the trochlea earlier in flexion and shifting the contact area off of the distal patella and more proximally, anteromedialization of the tibial tubercle aids in realigning the extensor mechanism and improving patellar tracking.[36] This technique also carries the risk of skin necrosis, fracture of the osteotomized segment, and non-union of the osteotomy. Complications can be reduced by meticulous soft-tissue dissection, minimal periosteal stripping, and preservation of the blood supply to the osteotomized fragment.[37]

Medial closing wedge patellar osteotomy

This technique creates a congruent PFJ by altering the shape of the trochlea. Often combined with trochleoplasty, this technique improves the PF maltracking and reduces the abnormal contact forces. A V-shaped wedge of bone is removed from the medial patellar facet, making it congruent to the trochlea.[38] However, this is technically demanding, and fracture and avascular necrosis of the patella have been reported.

Trochleoplasty

Trochleoplasty is a surgical option in patients with patella instability with severe trochlear dysplasia (Dejour C and B). It involves subchondral deepening and wedge osteotomy of the distal femur. Various types of trochleoplasty have been described, which include:[39,40]

  1. Lateral facet elevation trochleoplasty: This type of trochleoplasty deepens the trochlear groove by augmenting the lateral femoral condyle.

  2. Bereiter’s Sulcus deepening trochleoplasty: This is a classic trochleoplasty, which involves deepening the sulcus.

  3. Recession wedge trochleoplasty: This type of trochleoplasty addresses the prominent supratrochlear spur and prevents the patella from overriding it and becoming unstable during knee flexion.

De-rotational distal femur osteotomy

The rotational deformity of the femur is often overlooked by surgeons while treating a patella-femoral pathology. An increased femoral anteversion of more than 20° predisposes to recurrent PF dislocations and subluxations.[41] This can be addressed with a distal metaphyseal de-rotation osteotomy, which can be fixed with plates or an intramedullary device.[42] However, this technique requires a good number of skills and proper training. This procedure also carries the risk of fat/air embolism, pulmonary embolism, hypotension, oxygen desaturation, and higher mortality. This can be overcome by predrilling the osteotomy and limiting reaming into the canal.[43]

Soft tissue balancing

Lateral retinaculum release and medial plication can be performed as an adjunct to bony procedures.

Patello-femoral arthroplasty

In a completely arthritic patella-femoral joint, patellafemoral arthroplasty is a viable option. An ideal candidate for this surgery is a young patient with severe PF arthritis not resolving with conventional treatments. Post-operative aggressive physiotherapy is necessary for favorable outcomes.

The RTSs after PF arthroplasty are reported between 64.7% and 91% for equal or higher levels of physical activity.[44] For low-impact sports, the post-operative outcomes were the best. The most common complications reported for this procedure are implant loosening and instability (21%), necessitating a re-operation.[45]

Novel and adjunctive techniques

Subchondroplasty

This is a novel technique used to address the subchondral insufficiency fractures (bone marrow edema on MRI) associated with cartilaginous softening. This involves percutaneous injection of calcium phosphate into the subchondral bone to stabilize the articular surface under the guidance of fluoroscopy[46] [Figure 4].

Subchondroplasty technique.
Figure 4:
Subchondroplasty technique.

Nanofracture and autologous matrix-induced chondrogenesis (AMIC)

Nanofracture involves the use of more precise needles (1 mm diameter and 9 mm deep) for bleeding the subchondral bone. This technique works on the principle of microfracture. However, the outcomes of nanofracture alone are poor, as MSCs are washed out of the nanofracture site by synovial fluid. The addition of a hyaluronic acid-based scaffold holds the MSCs at the microfracture site and enhances the quality of fibrocartilage formed.[47] This technique is known as AMIC [Figure 5]. This can also be done arthroscopically. Behrendt et al. reported great clinical outcomes with AMIC; however, RCTs are awaited.[48]

Autologous matrix-induced chondrogenesis.
Figure 5:
Autologous matrix-induced chondrogenesis.

RTS AND PERFORMANCE OUTCOMES

RTSs remain the most important concern for the athletes. An early RTS is desirable. The RTS rate has been reported across various studies. We present to you a summary of various treatment modalities. [49,50]

Non-operative

With comprehensive physiotherapy and rehabilitation, 70– 90% of elite athletes in the early stages of chondromalacia patella can return to pre-injury levels within 3–6 months.

Post-cartilage restoration

RTS rates for high-level athletes after ACI/MACI in the PFJ range from 65 to 85%, with timelines averaging 11–18 months. [49,50] Success is higher with concomitant realignment when indicated.

Post-realignment

MPFL reconstruction yields more than 90% stability. RTS rates are high, but performance-based metrics (power, agility) may take 9–12 months to fully recover. [49,50]

CONCLUSION

The management of CMP in elite athletes requires a personalized, multi-modal strategy. Foundational rehabilitation focusing on load management and neuromuscular control remains paramount. Recent advances in biologics and precision surgery offer promising adjuncts for refractory cases or significant structural lesions. The ultimate goal is a safe, timely, and durable return to elite performance, guided by objective biomarkers and a shared decision-making model.

Author’s contributions:

SKT: Designed the study, literature review, methodology, editing, intellectual input; SK: Conceptualization, methodology, writing - original draft; AB: Methodology, formal analysis, project administration; MJ: Writing - Review and editing, supervision, visualization, software.

Declarations

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient’s consent is not required as there are no patients in this study.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Availability of data and materials:

This study doesn’t have any data to share.

Financial support and sponsorship: Nil.

References

  1. , , , . Patellofemoral pain in athletes: Clinical perspectives. Open Access J Sports Med. 2017;8:189-203.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , . Chondromalacia patella In: StatPearls. Treasure Island, FL: StatPearls Publishing; . Available from: https://www.ncbi.nlm.nih.gov/books/nbk459195 [Last accessed on 2026 Feb 07]
    [Google Scholar]
  3. , , , , , , et al. Incidence and prevalence of patellofemoral pain: A systematic review and meta-analysis. PLoS One. 2018;13:e0190892.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , . Factors of patellar instability: An anatomic radiographic study. Knee Surg Sports Traumatol Arthrosc. 1994;2:19-26.
    [CrossRef] [PubMed] [Google Scholar]
  5. . Roentgenographs and anatomic studies on the femoropatellar joint: With special reference to chondromalacia patellae. Acta Orthop. 1941;12:319-410.
    [CrossRef] [Google Scholar]
  6. , , , , , , et al. Morphometric assessment of the patella in healthy, chondromalacia and meniscopathy individuals: A retrospective study. BMC Musculoskelet Disord. 2025;26:771.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , . Medial patellofemoral ligament reconstruction and lateral retinacular lengthening from a lateral approach. Arthrosc Tech. 2021;10:e987-94.
    [CrossRef] [Google Scholar]
  8. , . Medial patellofemoral ligament repair: Still a relevant treatment for patellar instability? Oper Tech Sports Med. 2023;31:151033.
    [CrossRef] [Google Scholar]
  9. . Ultrasonographic assessment of quadriceps and patellar tendon thicknesses in patients with patellofemoral pain syndrome. Acta Orthop Traumatol Turc. 2019;53:272-7.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , . Evidence-based framework for a pathomechanical model of patellofemoral pain: 2017 Patellofemoral pain consensus statement from the 4th international patellofemoral pain research retreat, Manchester, UK: Part 3. Br J Sports Med. 2017;51:1713-23.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , . Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): Morphological assessment. Osteoarthritis Cartilage. 2006;14:46-75. 10.1016/j.joca.2006.02.026
    [CrossRef] [PubMed] [Google Scholar]
  12. . The etiology of chondromalacia patellae. J Bone Joint Surg Br. 1961;43(B):752-7.
    [CrossRef] [PubMed] [Google Scholar]
  13. , . Applied biomechanics of the patella. Clin Orthop Relat Res. 2001;389:9-14.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , . Spiral CT arthrography of the knee: Technique and value in the assessment of internal derangement of the knee. Eur Radiol. 2002;12:1800-10.
    [CrossRef] [PubMed] [Google Scholar]
  15. , . Understanding ultrasound power doppler synovitis at clinically quiescent joints and thermographic joint inflammation assessment in patients with rheumatoid arthritis. Diagnostics (Basel). 2024;14:2384.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , . Nordic hamstring exercises in functional knee rehabilitation after anterior cruciate ligament reconstruction: A prospective, randomised, controlled study. Sci Rep. 2023;13:19039.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , . Pain-guided activity modification during treatment for patellar tendinopathy: A feasibility and pilot randomized clinical trial. Pilot Feasibility Stud. 2021;7:58.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , . Treatment of anterior knee pain due to chondromalacia patellae with platelet-rich plasma and hyaluronic acid in young and middle-aged adults, a cohort study. Arch Orthop Trauma Surg. 2024;144:3969-76.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , . The role of viscosupplementation in patellar chondropathy. Ther Adv Musculoskelet Dis 2021:13.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: Results at 5 years of a double-blind, randomized controlled trial. Am J Sports Med. 2019;47:347-54.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , . A novel biological approach to treat chondromalacia patellae. PLoS One. 2013;8:e64569.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , . Chondromalacia patellae: Current options and emerging cell therapies. Stem Cell Res Ther. 2021;12:412.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , , . Outcomes after knee microfracture of chondral defects in alpine ski racers. J Knee Surg. 2014;27:407-10.
    [CrossRef] [PubMed] [Google Scholar]
  24. , . Microfracture for the treatment of cartilage defects in the knee joint-A golden standard? J Clin Orthop Trauma. 2016;7:145-52.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , . Isolated osteochondral autograft transplantation for a focal chondral defect of the patella. Arthrosc Tech. 2025;14:103673.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , . Osteochondral autologous transplantation for treating patellar high-grade chondral defects: A systematic review. Orthop J Sports Med 2019:7.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , , . Osteochondral allograft transplant of the patella using femoral condylar allografts: Magnetic resonance imaging and clinical outcomes at minimum 2-year follow-up. Orthop J Sports Med 2020:8.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , , , , et al. Long-term results of arthroscopic matrix-assisted autologous chondrocyte transplantation: A prospective follow-up at 15 years. Am J Sports Med. 2020;48:2994-3001.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , , . Radiographic landmarks for tunnel placement in reconstruction of the medial patellofemoral ligament. Knee Surg Sports Traumatol Arthrosc. 2012;20:2380-4.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , , , , et al. Complication rates after medial patellofemoral ligament reconstruction range from 0% to 32% with 0% to 11% recurrent instability: A systematic review. Arthroscopy. 2023;39:1345-56.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , , . Tibial tubercle osteotomy to unload the patellofemoral joint. J Cartilage Joint Preserv. 2023;3:100112.
    [CrossRef] [Google Scholar]
  32. . Advancement of the tibial tuberosity. Clin Orthop Relat Res. 1976;115:225-30.
    [CrossRef] [Google Scholar]
  33. , , , . A review of wound healing following Maquet osteotomy. Knee. 2004;11:463-7.
    [CrossRef] [PubMed] [Google Scholar]
  34. . Evaluation of the roux-elmslie-trillat procedure for knee extensor realignment. Am J Sports Med. 1982;10:303-10.
    [CrossRef] [PubMed] [Google Scholar]
  35. . Anteromedialization of the tibial tuberosity for patellofemoral malalignment. Clin Orthop Relat Res (177):176-81.
    [CrossRef] [Google Scholar]
  36. . Diagnosis and treatment of patients with patellofemoral pain. Am J Sports Med. 2002;30:447-56.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , , . Medial open wedge high tibial osteotomy: Can delayed or nonunion be predicted? Clin Orthop Relat Res. 2014;472:1217-23.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , , . Medial closing-wedge patellar osteotomy in patients with patellofemoral instability. Arthrosc Tech. 2024;13:102848.
    [CrossRef] [PubMed] [Google Scholar]
  39. , . Current concepts on trochleoplasty procedures for the surgical treatment of trochlear dysplasia. Knee Surg Sports Traumatol Arthrosc. 2014;22:2531-9.
    [CrossRef] [PubMed] [Google Scholar]
  40. , , , , , , et al. Complications and outcomes of trochleoplasty for patellofemoral instability: A systematic review and meta-analysis of 1000 trochleoplasties. Orthop Traumatol Surg Res. 2021;107:103035.
    [CrossRef] [PubMed] [Google Scholar]
  41. , , , , , , et al. Derotational distal femoral osteotomy for patients with recurrent patellar instability and increased femoral antetorsion improves knee function and adequately treats both torsional and valgus malalignment. Knee Surg Sports Traumatol Arthrosc. 2023;31:3091-7.
    [CrossRef] [PubMed] [Google Scholar]
  42. , , , , . Distal femoral derotational osteotomy for excessive femoral anteversion. Arthrosc Tech. 2025;14:103522.
    [CrossRef] [PubMed] [Google Scholar]
  43. . Femoral derotational osteotomies. Curr Rev Musculoskelet Med. 2018;11:272-9.
    [CrossRef] [PubMed] [Google Scholar]
  44. , , , , . Return to sports and recreational activities after patellofemoral arthroplasty: A systematic review. J ISAKOS. 2025;14:100925.
    [CrossRef] [PubMed] [Google Scholar]
  45. , , , . Outcomes of patellofemoral joint arthroplasty compared with total knee arthroplasty for osteoarthritis: A population-based cohort study using data from the national joint registry and hospital episode statistics for England. Bone Joint J. 2025;107(B):514-21.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , . Knee subchondroplasty for management of subchondral bone cysts: A novel treatment method. Singapore Med J. 2021;62:492-6.
    [CrossRef] [PubMed] [Google Scholar]
  47. , . Focal knee cartilage defect treatment with nanofracture and all-arthroscopic autologous matrix-induced chondrogenesis using dry arthroscopy. Arthrosc Tech. 2025;14:103272.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , , , , , et al. Autologous matrix-induced chondrogenesis provides better outcomes in comparison to autologous minced cartilage implantation in the repair of knee chondral defects. Knee Surg Sports Traumatol Arthrosc. 2024;32:3023-30.
    [CrossRef] [PubMed] [Google Scholar]
  49. , , . Rehabilitation and return to sports of patellofemoral dislocation and instability In: Orthopaedic Sports Medicine. Cham: Springer; . p. :1-14. Available from: https://link.springer.com/rwe/10.1007/978-3-030-65430-6_196-1 [Last accessed on 2026 Feb 04].
    [CrossRef] [Google Scholar]
  50. , , , , . Return to play after knee articular cartilage restoration: Surgical options, rehabilitation protocols, and performance Outcomes. Curr Rev Musculoskelet Med. 2023;16:575-86.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections